Case Study | July 24, 2012

New Positioning System Facilitates Cancer Treatments

Agnesian HealthCare’s Protura robotic patient positioning system helps it provide precise radiation therapy to patients in its local community

New Positioning System Facilitates Cancer Treatments

The Protura positioning system integrates with existing IGRT solutions and the linac to provide all-in-one motion management. The patient can be positioned with 6 degrees of freedom corrections from outside the treatment room.

Each year, community cancer centers treat about 85 percent of cancer patients in the United States.1 Agnesian HealthCare Cancer Care Services brings exceptional cancer care closer to patients through its Central Wisconsin Cancer Program (CWCP). Agnesian HealthCare’s Fond du Lac location is one of a handful of image-guided radiation therapy (IGRT) and stereotactic body radiation therapy (SBRT) providers in the state, and it is the only facility in Wisconsin to have installed a robotic 6DOF patient positioning system.

The Protura robotic patient positioning system, a product of CIVCO Medical Solutions, is capable of positioning patients in 6DOF with sub-millimeter and sub-degree accuracy. Agnesian HealthCare has used it to facilitate IGRT and to implement SBRT treatments.

“SBRT requires highly conformal treatment planning as well as the tools to confidently deliver that treatment,” said Tim Lemond, Agnesian HealthCare chief physicist. “That means sub-millimeter and sub-degree accuracy and a robotic 6DOF table with the ability to correct for translational and rotational errors. The Protura system meets these requirements and enables us to deliver high-quality SBRT treatments.”

Agnesian HealthCare’s Cancer Care Services sees patients from a wide area of East Central Wisconsin. The delivery of SBRT at a community center allows these patients to receive highly advanced treatment closer to home.

“With the addition of the 6DOF system, we are bringing the highest technology and the best treatment techniques to patients in our area,” said Heather Bowen, MBA, RT (R)(T)(CT), radiation oncology supervisor at Agnesian HealthCare. “These patients get to receive treatment near their families and near their jobs. It’s unique for us to be able to provide that without requiring our patients to travel.” Agnesian HealthCare associates and providers are proud to provide this level of care.

Clinically, the addition of the robotic 6DOF system has improved treatment confidence and patient care. “Whether we are treating head and neck cases with intensity-modulated radiation therapy (IMRT) or delivering SBRT, accurately positioning the patient gives us clinical confidence that we are using the data from 3-D imaging to deliver treatment only to the tumor,” said Timothy Korytko, M.D., a board-certified radiation oncologist with Agnesian HealthCare. “We’re able to use smaller margins and minimize the side effects of treatment. Using the Protura system provides the best results and care for our patients.”

Through the addition of a 6DOF robotic patient positioning system, Agnesian HealthCare CWCP has brought cutting-edge radiation treatment technology into a community cancer care setting, providing an example for community cancer centers across the country.

Reference:
1. http://ncccp.cancer.gov/Media/FactSheet.htm

Case study supplied by CIVCO Medical Solutions.

Related Content

News | Radiation Therapy | May 06, 2021
May 6, 2021 — Individuals living with severe...
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
May 5, 2021 — Lung cancer is the third most common cance
The emergence of #therapeutic #radiopharmaceuticals and its adoption in #cancer care provide one more weapon in combating cancer

Getty Images

Feature | Radiation Oncology | May 04, 2021 | By Vinay Shivaprasad
The term nuclear medicine is associated with the diag
Despite receiving high radiation doses to their tumors, lung cancer patients treated with technique that spares a large part of the esophagus did not develop severe inflammation of the esophagus

Getty Images

News | Lung Imaging | April 30, 2021
April 30, 2021 — For many patients with localized lung cance...
#prostatecancer During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

Getty Images

News | Prostate Cancer | April 30, 2021
April 30, 2021 — During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate canc
A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)

A 63-year-old multiple myeloma patient, with skeletal pain. New FDG avid axillary lymphadenopathy 62 days (9 weeks) after second mRNA vaccination dose. Image used with permission of the Radiological Society of North America (RSNA)

Feature | Coronavirus (COVID-19) | April 29, 2021 | By Melinda Taschetta-Millane
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases.

Image courtesy of Accuray

News | Stereotactic Body Radiation Therapy (SBRT) | April 23, 2021
April 23, 2021 — A phase 1 clinical trial led by investigators at the...